Anne Touratier
Research Subjects
Research Interests
Anne Touratier has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Fediaevsky
Animal Health Unit, French General Directorate for Food (DGAL), Ministry of Agriculture, the Food Processing Industry and Forestry, Paris, France
1 shared publication - Corinne Sailleau
ANSES/INRA/ENVA-UPEC
1 shared publication - Cyril Viarouge
UMR 1161 Virologie, Laboratory for Animal Health, INRAE, Department of Animal Health, Ecole Nationale Vétérinaire d’Alfort, ANSES, Université Paris-Est, 94700 Maisons-Alfort, France
1 shared publication - Didier Calavas
Anses-Lyon, Unité Epidémiologie, 31 avenue Tony Garnier, 69364 Lyon Cedex 07, France
1 shared publication - Emmanuel Bréard
ANSES/INRA/ENVA-UPEC
1 shared publication - Eric Collin
French National Organisation for Veterinary Technical Groups (SNGTV), Paris, France
1 shared publication
Latest Publications
- Open Access
- 14 October 2014
- Published by Springer Nature in BMC Veterinary Research
- Vol. 10 (1) , 248
Spread and impact of the Schmallenberg virus epidemic in France in 2012-2013
The Schmallenberg virus (SBV) emerged in Europe in 2011 and caused a widespread epidemic in ruminants. In France, SBV emergence was monitored through a national multi-stakeholder surveillance and investigation system. Based on the monitoring data collected from January 2012 to August 2013, we describe the spread of SBV in France during two seasons of dissemination (vector seasons 2011 and 2012) and we provide a large-scale assessment of the impact of this new disease in ruminants. SBV impact in infected herds was primarily due to the birth of stillborns or deformed foetuses and neonates. Congenital SBV morbidity level was on average moderate, although higher in sheep than in other ruminant species. On average, 8% of lambs, 3% of calves and 2% of kids born in SBV-infected herds showed typical congenital SBV deformities. In addition, in infected herds, farmers reported retrospectively a lower prolificacy during the vector season, suggesting a potential impact of acute SBV infection during mating and early stages of gestation. Due to the lack of available control and prevention measures, SBV spread quickly in the naive ruminant population. France continues to monitor for SBV, and updated information is made available online on a regular basis [ http://www.plateforme-esa.fr/ ]. Outbreaks of congenital SBV are expected to occur sporadically from now on, but further epidemics may also occur if immunity at population level declines.
- 14 October 2014
- Published by Springer Nature in BMC Veterinary Research
- Vol. 10 (1) , 248
Open AccessSpread and impact of the Schmallenberg virus epidemic in France in 2012-2013
The Schmallenberg virus (SBV) emerged in Europe in 2011 and caused a widespread epidemic in ruminants. In France, SBV emergence was monitored through a national multi-stakeholder surveillance and investigation system. Based on the monitoring data collected from January 2012 to August 2013, we describe the spread of SBV in France during two seasons of dissemination (vector seasons 2011 and 2012) and we provide a large-scale assessment of the impact of this new disease in ruminants. SBV impact in infected herds was primarily due to the birth of stillborns or deformed foetuses and neonates. Congenital SBV morbidity level was on average moderate, although higher in sheep than in other ruminant species. On average, 8% of lambs, 3% of calves and 2% of kids born in SBV-infected herds showed typical congenital SBV deformities. In addition, in infected herds, farmers reported retrospectively a lower prolificacy during the vector season, suggesting a potential impact of acute SBV infection during mating and early stages of gestation. Due to the lack of available control and prevention measures, SBV spread quickly in the naive ruminant population. France continues to monitor for SBV, and updated information is made available online on a regular basis [ http://www.plateforme-esa.fr/ ]. Outbreaks of congenital SBV are expected to occur sporadically from now on, but further epidemics may also occur if immunity at population level declines.